Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis.
adherence
airway clearance
chest physical therapy
cystic fibrosis
high-frequency chest wall compressions
Journal
Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
13
12
2018
medline:
5
3
2020
entrez:
13
12
2018
Statut:
ppublish
Résumé
Historically, studies of adherence to airway clearance therapy in cystic fibrosis (CF) have relied on self-reporting. We compared self-reported airway clearance therapy adherence to actual usage data from home high-frequency chest wall compressions (HFCWC) vests and identified factors associated with overestimation of adherence in self-reports. Pediatric patients who perform airway clearance therapy with a HFCWC vest were eligible to participate. Objective adherence data were obtained from the HFCWC device, which records cumulative utilization time. Two readings at least 5 weeks apart were collected. Objective adherence was recorded as a ratio of mean-to-prescribed daily use (%). Self-reported adherence data were collected with a caregiver survey at enrollment. Adherence rates were categorized as low (< 35% of prescribed), moderate (36-79% of prescribed), and high (≥ 80% of prescribed). An overestimation was present when self-reported adherence was at least one category higher than objective adherence. In the final sample ( Self-reports overestimated actual adherence to airway clearance therapy, and the overestimation increased with treatment occurring in multiple households and prescribed therapy duration. Among participants with prescribed airway clearance therapy ≥ 60 min, overestimation increased with lower income. Objective measures of adherence are needed, particularly for lower-income children and those receiving treatments in multiple locations.
Sections du résumé
BACKGROUND
BACKGROUND
Historically, studies of adherence to airway clearance therapy in cystic fibrosis (CF) have relied on self-reporting. We compared self-reported airway clearance therapy adherence to actual usage data from home high-frequency chest wall compressions (HFCWC) vests and identified factors associated with overestimation of adherence in self-reports.
METHODS
METHODS
Pediatric patients who perform airway clearance therapy with a HFCWC vest were eligible to participate. Objective adherence data were obtained from the HFCWC device, which records cumulative utilization time. Two readings at least 5 weeks apart were collected. Objective adherence was recorded as a ratio of mean-to-prescribed daily use (%). Self-reported adherence data were collected with a caregiver survey at enrollment. Adherence rates were categorized as low (< 35% of prescribed), moderate (36-79% of prescribed), and high (≥ 80% of prescribed). An overestimation was present when self-reported adherence was at least one category higher than objective adherence.
RESULTS
RESULTS
In the final sample (
CONCLUSIONS
CONCLUSIONS
Self-reports overestimated actual adherence to airway clearance therapy, and the overestimation increased with treatment occurring in multiple households and prescribed therapy duration. Among participants with prescribed airway clearance therapy ≥ 60 min, overestimation increased with lower income. Objective measures of adherence are needed, particularly for lower-income children and those receiving treatments in multiple locations.
Identifiants
pubmed: 30538158
pii: respcare.06436
doi: 10.4187/respcare.06436
pmc: PMC6818680
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
176-181Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK072482
Pays : United States
Informations de copyright
Copyright © 2019 by Daedalus Enterprises.
Références
Respir Care. 2017 Jul;62(7):920-927
pubmed: 28424226
COPD. 2012 Jun;9(3):251-8
pubmed: 22497533
J Pediatr Psychol. 2010 Oct;35(9):1028-37
pubmed: 20304772
Med Care. 2002 Sep;40(9):794-811
pubmed: 12218770
Pediatr Pulmonol. 2012 Mar;47(3):283-91
pubmed: 21905271
J Cyst Fibros. 2011 Jul;10(4):258-64
pubmed: 21458391
J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):250-7
pubmed: 23648790
Fam Med. 2005 Nov-Dec;37(10):712-8
pubmed: 16273450
J Cyst Fibros. 2008 Sep;7(5):359-67
pubmed: 18304896
J Cyst Fibros. 2006 Aug;5(3):177-85
pubmed: 16679071
J Pediatr Psychol. 2006 Sep;31(8):846-58
pubmed: 16401680
J Am Pharm Assoc (2003). 2005 Mar-Apr;45(2):151-9
pubmed: 15868757
Med Care. 2008 Nov;46(11):1134-9
pubmed: 18953223
Inflamm Bowel Dis. 2009 Apr;15(4):589-93
pubmed: 18985746
J Adv Nurs. 1996 Aug;24(2):385-90
pubmed: 8858445
Pediatr Pulmonol. 1993 Feb;15(2):75-88
pubmed: 8474788
Pediatr Pulmonol. 2010 Mar;45(3):291-300
pubmed: 20146387
J Pediatr Psychol. 2008 Oct;33(9):916-36; discussion 937-8
pubmed: 17846042
Pediatr Pulmonol. 2015 Dec;50(12):1244-52
pubmed: 26436321
Chest. 2011 Aug;140(2):425-432
pubmed: 21330381